title: Cancer-associated hemolytic-uremic syndrome with spontaneous resolution. A case report.
abstract: A case of cancer-related hemolytic-uremic syndrome is reported. The patient presented a spontaneous recovery, which is unusual in this clinical picture. Mitomycin C is regarded as responsible for this toxic event in most cases. The case history reported here is discussed in relation to dose and scheduling of mitomycin C, and a safe maximum dosage is suggested.
authors.affiliation: Istituto di Clinica Medica III, Università La Sapienza, Roma, Italy.
authors.forename: P
authors.initials: P
authors.lastname: Seminara
authors.forename: F
authors.initials: F
authors.lastname: Franchi
authors.forename: S
authors.initials: S
authors.lastname: Abdolrahimzadeh
authors.forename: M
authors.initials: M
authors.lastname: Gozzer
authors.forename: C
authors.initials: C
authors.lastname: Barone
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use; D006463:Hemolytic-Uremic Syndrome / Q000209:etiology*; D006801:Humans; D008875:Middle Aged; D016685:Mitomycin; D008937:Mitomycins / Q000627:therapeutic use; D012004:Rectal Neoplasms / Q000150:complications* / Q000188:drug therapy; D012075:Remission, Spontaneous
chemical_list: D000970:Antineoplastic Agents; D008937:Mitomycins; D016685:Mitomycin; D005472:Fluorouracil